These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1292 related items for PubMed ID: 9068931

  • 21. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding.
    Sánchez C, Hyttel J.
    Cell Mol Neurobiol; 1999 Aug; 19(4):467-89. PubMed ID: 10379421
    [Abstract] [Full Text] [Related]

  • 22. The pharmacogenetics of the selective serotonin reuptake inhibitors.
    Brøsen K.
    Clin Investig; 1993 Dec; 71(12):1002-9. PubMed ID: 8124052
    [Abstract] [Full Text] [Related]

  • 23. Selective serotonin reuptake inhibitors in affective disorders--I. Basic pharmacology.
    Goodnick PJ, Goldstein BJ.
    J Psychopharmacol; 1998 Dec; 12(3 Suppl B):S5-20. PubMed ID: 9808077
    [Abstract] [Full Text] [Related]

  • 24. Pharmacokinetic optimisation of therapy with newer antidepressants.
    Goodnick PJ.
    Clin Pharmacokinet; 1994 Oct; 27(4):307-30. PubMed ID: 7834966
    [Abstract] [Full Text] [Related]

  • 25. Pharmacokinetic drug interactions of new antidepressants: a review of the effects on the metabolism of other drugs.
    Richelson E.
    Mayo Clin Proc; 1997 Sep; 72(9):835-47. PubMed ID: 9294531
    [Abstract] [Full Text] [Related]

  • 26. Some aspects of genetic polymorphism in the biotransformation of antidepressants.
    Brøsen K.
    Therapie; 2004 Sep; 59(1):5-12. PubMed ID: 15199661
    [Abstract] [Full Text] [Related]

  • 27. Newer antidepressants and the cytochrome P450 system.
    Nemeroff CB, DeVane CL, Pollock BG.
    Am J Psychiatry; 1996 Mar; 153(3):311-20. PubMed ID: 8610817
    [Abstract] [Full Text] [Related]

  • 28. The potential for clinically significant drug-drug interactions involving the CYP 2D6 system: effects with fluoxetine and paroxetine versus sertraline.
    Preskorn SH, Shah R, Neff M, Golbeck AL, Choi J.
    J Psychiatr Pract; 2007 Jan; 13(1):5-12. PubMed ID: 17242587
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Is therapeutic drug monitoring a case for optimizing clinical outcome and avoiding interactions of the selective serotonin reuptake inhibitors?
    Rasmussen BB, Brøsen K.
    Ther Drug Monit; 2000 Apr; 22(2):143-54. PubMed ID: 10774624
    [Abstract] [Full Text] [Related]

  • 32. Inhibition of CYP2C9 by selective serotonin reuptake inhibitors in vitro: studies of phenytoin p-hydroxylation.
    Schmider J, Greenblatt DJ, von Moltke LL, Karsov D, Shader RI.
    Br J Clin Pharmacol; 1997 Nov; 44(5):495-8. PubMed ID: 9384467
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Recent pharmacologic advances in antidepressant therapy for the elderly.
    Preskorn SH.
    Am J Med; 1993 May 24; 94(5A):2S-12S. PubMed ID: 8503477
    [Abstract] [Full Text] [Related]

  • 36. Targeted pharmacotherapy in depression management: comparative pharmacokinetics of fluoxetine, paroxetine and sertraline.
    Preskorn S.
    Int Clin Psychopharmacol; 1994 Jun 24; 9 Suppl 3():13-9. PubMed ID: 7963446
    [Abstract] [Full Text] [Related]

  • 37. CYP2D6 inhibition by selective serotonin reuptake inhibitors: analysis of achievable steady-state plasma concentrations and the effect of ultrarapid metabolism at CYP2D6.
    Lam YW, Gaedigk A, Ereshefsky L, Alfaro CL, Simpson J.
    Pharmacotherapy; 2002 Aug 24; 22(8):1001-6. PubMed ID: 12173784
    [Abstract] [Full Text] [Related]

  • 38. [The transfer of selective serotonin reuptake inhibitors to human milk].
    Nordeng H, Bergsholm YK, Bøhler E, Spigset O.
    Tidsskr Nor Laegeforen; 2001 Jan 20; 121(2):199-203. PubMed ID: 11475200
    [Abstract] [Full Text] [Related]

  • 39. Serotonin selective reuptake inhibitor drug interactions and the cytochrome P450 system.
    Ereshefsky L, Riesenman C, Lam YW.
    J Clin Psychiatry; 1996 Jan 20; 57 Suppl 8():17-24; discussion 25. PubMed ID: 8698676
    [Abstract] [Full Text] [Related]

  • 40. Selective serotonin reuptake inhibitors: pharmacologic profiles and potential therapeutic distinctions.
    Finley PR.
    Ann Pharmacother; 1994 Dec 20; 28(12):1359-69. PubMed ID: 7696728
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 65.